JPS51125042A - Process for manufacture of 111epiiprostanic acid derivatives - Google Patents

Process for manufacture of 111epiiprostanic acid derivatives

Info

Publication number
JPS51125042A
JPS51125042A JP50095328A JP9532875A JPS51125042A JP S51125042 A JPS51125042 A JP S51125042A JP 50095328 A JP50095328 A JP 50095328A JP 9532875 A JP9532875 A JP 9532875A JP S51125042 A JPS51125042 A JP S51125042A
Authority
JP
Japan
Prior art keywords
manufacture
acid derivatives
derivatives
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP50095328A
Other languages
English (en)
Japanese (ja)
Inventor
Bouraa Jiyan
Bureikunii Marion Keisu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of JPS51125042A publication Critical patent/JPS51125042A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP50095328A 1974-08-05 1975-08-05 Process for manufacture of 111epiiprostanic acid derivatives Pending JPS51125042A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB34334/74A GB1486832A (en) 1974-08-05 1974-08-05 Prostanoic acid derivatives

Publications (1)

Publication Number Publication Date
JPS51125042A true JPS51125042A (en) 1976-11-01

Family

ID=10364354

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50095328A Pending JPS51125042A (en) 1974-08-05 1975-08-05 Process for manufacture of 111epiiprostanic acid derivatives

Country Status (17)

Country Link
JP (1) JPS51125042A (no)
AT (1) ATA606175A (no)
AU (1) AU502146B2 (no)
BE (1) BE832098A (no)
CA (1) CA1067490A (no)
DD (1) DD124595A5 (no)
DE (1) DE2534989A1 (no)
DK (1) DK354575A (no)
FI (1) FI752196A (no)
FR (1) FR2281101A1 (no)
GB (1) GB1486832A (no)
IE (1) IE43198B1 (no)
IN (1) IN141386B (no)
NL (1) NL7509078A (no)
NO (1) NO752734L (no)
SE (1) SE7508779L (no)
ZA (1) ZA754491B (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004346080A (ja) * 1992-09-21 2004-12-09 Allergan Inc 医薬としての非酸性シクロペンタンヘプタン酸,2−シクロアルキルまたはアリールアルキル誘導体

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1554030A (en) * 1976-05-10 1979-10-17 Upjohn Co Prostaglandins
GB8625325D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US6184250B1 (en) 1993-08-03 2001-02-06 Alcon Laboratories, Inc. Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004346080A (ja) * 1992-09-21 2004-12-09 Allergan Inc 医薬としての非酸性シクロペンタンヘプタン酸,2−シクロアルキルまたはアリールアルキル誘導体

Also Published As

Publication number Publication date
IN141386B (no) 1977-02-19
NL7509078A (nl) 1976-02-09
GB1486832A (en) 1977-09-28
IE43198B1 (en) 1981-01-14
IE43198L (en) 1976-02-05
DE2534989A1 (de) 1976-02-26
DD124595A5 (no) 1977-03-02
ZA754491B (en) 1976-06-30
SE7508779L (sv) 1976-02-06
CA1067490A (en) 1979-12-04
AU502146B2 (en) 1979-07-12
FR2281101B1 (no) 1978-11-10
NO752734L (no) 1976-02-06
DK354575A (da) 1976-02-06
AU8310275A (en) 1977-01-20
ATA606175A (de) 1978-05-15
BE832098A (fr) 1976-02-04
FR2281101A1 (fr) 1976-03-05
FI752196A (no) 1976-02-06

Similar Documents

Publication Publication Date Title
EG12063A (en) Process for preparing of 16-oxygenated phosphanoic acid derivatives
HU172448B (hu) Sposob poluchenija proizvodnykh cef-3-em-4-karbonovojj kisloty
CS188260B2 (en) Process for preparing diethylestere of carbo-n-butoxyaldiminomethanphosphonic acid
EG11847A (en) Process for preparing of novel acid derivatives
YU118575A (en) Process for obtaining new derivatives of 13-thiaprostanoic acid
CS189642B2 (en) Process for preparing derivatives of cephalosporic acid
GB1519861A (en) Prostanoic acid derivatives and process for their manufacture
HU170859B (hu) Sposob poluchenija novykh proizvodnykh 6-skobka-al'fa-ureido-fenilacetilamido-skobka zakryta-penam-3-karbonovojj kisloty
HU171207B (hu) Sposob poluchenija proizvodnykh cef-3-em-4-karbonovojj kisloty
HU171513B (hu) Sposob poluchenija proizvodnykh 7-beta-acilamino-7al'fa-alkok-icef-3-em-4-karbonovojj kisloty
CS181798B2 (en) Process for preparing derivatives of prostanic acid
JPS51125042A (en) Process for manufacture of 111epiiprostanic acid derivatives
CS192518B2 (en) Method of producing derivatives of 3-cinnolincarboxylic acid
HU172891B (hu) Sposob poluchenija proizvodnykh 7-amino-cef-3-em-4-karbonovojj kisloty
ZA752065B (en) Process for the manufacture of salts of poly-alpha- hydroxyacrylic acid
JPS51125038A (en) Process for manufacture of cycloalkyl derivatives of 11aryloxyy33aminoo22propanols
JPS51125043A (en) Process for manufacture of 19*200bissnorr prostanic acid
HU173651B (hu) Sposob poluchenija proizvodnykh beta-amino-7-al'fa-metoksi-cef-3-em-4-karbonovojj kisloty
CH609971A5 (en) Process for the preparation of prostanoic acid derivatives
YU37170B (en) Process for obtaining penicillnic acid derivatives
HU171908B (hu) Sposob poluchenija proizvodnykh 5-sul'famoil-antranilovoj kisloty
HU171357B (hu) Sposob poluchenija proizvodnykh cef-3-em-4-karbonovojj kisloty
HU172892B (hu) Sposob poluchenija proizvodnykh cef-3-em-4-karbonovojj kisloty
HU171053B (hu) Sposob poluchenija novykh proizvodnykh 7-skobka-2-ureido-acetamido-skobka zakryta-3-geterociklicheskijj-tiometil-cef-3-em-4-karbonovojj kisloty
HU173324B (hu) Sposob poluchenija proizvodnykh 7-acilamido-3-metil-3-cefem-4-karbonovykh kislot iz slozhnykh efirov sul'foksidov 6-acilamido-penicillanykh kislot